CHE Stock Cash Flow Statements

Chemed Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Free Cash Flow

Capital Expenditure

Chemed Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2018-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-03-31	2008-03-31

cash flows from operating activities
net income	52,493,000	71,757,000	90,319,000	75,776,000	70,887,000	65,017,000	90,053,000	74,958,000	53,377,000	54,121,000	62,126,000	56,873,000	66,456,000	64,169,000	74,625,000	72,003,000	56,522,000	65,400,000	113,752,000	67,722,000	82,101,000	55,891,000	65,580,000	58,947,000	50,400,000	44,996,000	28,833,000	26,975,000	24,537,000	24,585,000	24,363,000	20,574,000	17,432,000	14,608,000	22,278,000	20,845,000	21,274,000	20,445,000	21,887,000	20,286,000	18,101,000	20,988,000	18,855,000	19,358,000	19,339,000	16,820,000
adjustments to reconcile net income to net cash provided
by operating activities:
depreciation and amortization	16,260,000	16,017,000	15,831,000	15,697,000	15,713,000	15,808,000	15,539,000	15,379,000	15,148,000	14,799,000	14,608,000	14,674,000	15,234,000	14,656,000	14,350,000	14,354,000	16,122,000	14,225,000	14,346,000	14,225,000	14,147,000	13,865,000	14,095,000	10,588,000	11,228,000	9,294,000	8,812,000	8,664,000	8,608,000	8,167,000	8,007,000	8,158,000	8,161,000	8,080,000	7,922,000	7,692,000	7,507,000	7,354,000	7,447,000	7,497,000	7,258,000	7,581,000	7,481,000	6,693,000	6,861,000	6,888,000
stock option expense	9,216,000	9,091,000	8,100,000	6,038,000	8,870,000	9,025,000	7,706,000	5,494,000	8,400,000	8,482,000	6,911,000	4,676,000	7,216,000	7,451,000	6,160,000	3,997,000	6,239,000	6,106,000	5,126,000	3,183,000	5,068,000	5,045,000	4,102,000	2,711,000	4,365,000	3,653,000	813,000	1,343,000	1,444,000	977,000	1,144,000	1,309,000	1,629,000	1,612,000	1,491,000	2,397,000	2,374,000	1,938,000	2,408,000	2,562,000	1,933,000	1,968,000	2,346,000	2,051,000	2,042,000
benefit for deferred income taxes	931,000	-14,174,000		175,000	3,002,000	-5,422,000				-3,195,000				-4,047,000												-2,807,000
noncash long-term incentive compensation	853,000	2,420,000		3,084,000	3,593,000	9,106,000		3,144,000	1,469,000	2,024,000		1,846,000	1,312,000	1,185,000		1,942,000	1,760,000	1,642,000		1,774,000	1,929,000	1,598,000		1,678,000	785,000	1,721,000	1,364,000	1,457,000	934,000	1,002,000	613,000	373,000	55,000	494,000	612,000				0	0	2,595,000	0
noncash directors' compensation			0	0			0	0			0	0			0	0			0	0			0	0
amortization of debt issuance costs	80,000	80,000	80,000	81,000	80,000	80,000	80,000	80,000	325,000	95,000	95,000	94,000	77,000	76,000	77,000	76,000	77,000	76,000	77,000	76,000	77,000	76,000	77,000	76,000	25,000	128,000	130,000	131,000	131,000	133,000	227,000	337,000													154,000	254,000
litigation settlements			0	0			0								0
changes in operating assets and liabilities:
increase in accounts receivable																											-7,928,000	22,744,000	-24,926,000			-27,700,000			-36,706,000	-21,866,000			3,280,000			-6,359,000	-16,724,000	-36,445,000
(increase)/decrease in inventories														-431,000
(increase)/decrease in prepaid expenses	-2,802,000	-4,430,000
decrease in accounts payable and other current liabilities	10,143,000	-22,592,000				-43,012,000				-24,109,000			6,331,000	-30,332,000				-18,369,000							3,736,000	-7,911,000		8,224,000	-9,538,000			-32,561,000			-698,000		301,000	-3,894,000			-12,137,000			-381,000	-7,900,000	-5,679,000
change in current income taxes	-48,050,000	37,286,000	6,727,000	6,231,000	-34,647,000	23,871,000	-566,000	10,449,000	-17,253,000	19,118,000	9,281,000	-10,304,000	-23,503,000	23,530,000	-4,652,000	10,493,000	-44,637,000	18,395,000	17,891,000	-28,091,000	13,566,000	10,159,000	242,000	2,168,000
net change in lease assets and liabilities	-241,000	169,000	-274,000	-291,000	-134,000	25,000	-532,000	154,000	-414,000	-632,000	1,158,000	-392,000	-38,000	743,000	-59,000	451,000	-412,000	-24,000	-377,000	296,000	1,440,000	-153,000	1,797,000
decrease/(increase) in other assets	45,392,000	3,034,000																-5,274,000				5,048,000
increase in other liabilities	570,000	951,000		2,618,000	2,398,000	13,332,000				5,313,000				2,958,000	-1,400,000	3,386,000			1,588,000	9,352,000			3,309,000	3,212,000	2,075,000	3,758,000	-2,442,000	397,000	2,569,000	726,000	1,564,000	3,080,000	-423,000	1,119,000	3,282,000	2,155,000	-748,000	5,241,000	-947,000	1,287,000	3,227,000			2,724,000	486,000	532,000
other sources	38,000	156,000				406,000							-483,000	351,000	311,000	672,000	-408,000	710,000	-61,000			388,000	122,000	440,000			278,000	60,000	129,000	202,000	144,000	409,000	-1,012,000	321,000	976,000	305,000	464,000	309,000	449,000	265,000	185,000	336,000	283,000	151,000	168,000	68,000
net cash from operating activities	138,606,000	32,744,000	164,913,000	90,518,000	77,517,000	84,549,000	108,563,000	28,927,000	132,317,000	60,492,000	100,199,000	52,017,000	56,580,000	101,090,000	63,570,000	112,988,000	25,320,000	106,719,000	86,877,000	124,590,000	188,496,000	89,326,000	63,604,000	128,738,000	43,714,000	65,193,000	43,446,000			5,896,000			51,192,000	76,525,000	8,141,000	22,682,000	44,274,000	10,381,000	56,809,000	2,586,000	48,541,000	37,713,000	12,626,000	7,651,000	25,101,000	39,531,000
cash flows from investing activities
capital expenditures	-15,808,000	-13,280,000	-12,761,000	-13,545,000	-11,062,000	-12,163,000	-11,779,000	-11,655,000	-16,400,000	-17,020,000	-18,259,000	-13,456,000	-12,961,000	-12,649,000	-14,203,000	-10,868,000	-15,907,000	-17,697,000	-16,161,000	-10,419,000	-12,354,000	-19,897,000	-13,269,000	-11,441,000	-15,664,000	-12,648,000	-11,348,000	-10,293,000	-8,553,000	-12,291,000	-11,323,000	-8,131,000	-6,687,000	-6,794,000	-5,406,000	-8,015,000	-6,456,000	-12,018,000	-8,499,000	-8,787,000	-6,173,000	-7,165,000	-6,518,000	-5,424,000	-3,376,000	-3,891,000
free cash flows	122,798,000	19,464,000	152,152,000	76,973,000	66,455,000	72,386,000	96,784,000	17,272,000	115,917,000	43,472,000	81,940,000	38,561,000	43,619,000	88,441,000	49,367,000	102,120,000	9,413,000	89,022,000	70,716,000	114,171,000	176,142,000	69,429,000	50,335,000	117,297,000	28,050,000	52,545,000	32,098,000			-6,395,000			44,505,000	69,731,000	2,735,000	14,667,000	37,818,000	-1,637,000	48,310,000	-6,201,000	42,368,000	30,548,000	6,108,000	2,227,000	21,725,000	35,640,000
proceeds from sale of fixed assets	368,000	112,000	255,000	144,000	2,830,000	86,000	134,000	146,000	214,000	146,000	293,000	280,000
business combinations, net of cash acquired	0	-225,000	0	-5,100,000	-85,000,000	-7,300,000	0	-3,689,000			-1,485,000	-394,000	0	-1,650,000													0			0	0	-250,000	-709,000			-4,400,000	-1,085,000	-415,000	0			0			-1,944,000
other uses	-41,000	-281,000	-14,000	-16,000	-257,000	-8,000		-240,000	-30,000	-139,000												-144,000					-797,000	129,000	-783,000	-128,000	249,000	-501,000							40,000	-727,000	-142,000	-344,000	-129,000	-157,000	-31,000	-122,000
net cash used by investing activities	-15,481,000	-13,674,000	-12,520,000	-18,517,000	-93,489,000	-19,385,000	-11,670,000	-15,438,000	-16,521,000	-17,013,000	-19,488,000	-14,279,000	-11,687,000	-13,948,000	-14,045,000	-10,410,000	-15,879,000	-17,423,000	-15,962,000	-10,220,000	-13,885,000	-21,493,000	-13,098,000	-149,213,000	-14,532,000	-13,917,000	-11,347,000	-16,863,000	-8,202,000	-12,294,000	-11,160,000	-8,352,000	-7,358,000	-8,272,000	-5,328,000	-12,244,000	-7,495,000	-12,122,000	-8,459,000	-13,236,000	-6,282,000	-7,416,000	-6,615,000	-5,554,000
cash flows from financing activities
purchases of treasury stock	-42,946,000	-33,222,000	-209,340,000	-57,821,000	-55,768,000	-38,460,000	-39,928,000	-14,344,000			-12,976,000	-24,325,000	-49,420,000	-27,794,000	-245,662,000	-163,731,000	-125,542,000	-41,107,000	-28,471,000	-24,975,000	-21,913,000	-100,235,000	-20,705,000	0	9,199,000	-81,125,000	-6,920,000			-40,610,000	-25,511,000	-32,982,000	-71,163,000			-2,206,000	-11,410,000	-1,431,000	-84,806,000	-1,222,000	-24,260,000	-15,000	-7,609,000	-2,516,000	-231,000	-16,263,000
proceeds from exercise of stock options	4,486,000	22,666,000	6,611,000	11,312,000	1,352,000	37,242,000	43,915,000	4,602,000	27,995,000	25,680,000	27,840,000	4,259,000	5,177,000	7,692,000	17,930,000	1,732,000	5,160,000	11,026,000	18,884,000	12,058,000	10,199,000	9,241,000	10,997,000	6,866,000	7,594,000	8,923,000	3,149,000	3,145,000	4,899,000	6,031,000	2,899,000	13,193,000	567,000	2,390,000	10,168,000
dividends paid	-7,217,000	-7,325,000	-7,498,000	-7,487,000	-6,057,000	-6,050,000	-6,056,000	-6,034,000	-5,727,000	-5,685,000	-5,626,000	-5,669,000	-5,400,000	-5,322,000	-5,559,000	-5,593,000	-5,427,000	-5,437,000	-5,440,000	-5,401,000	-5,108,000	-5,130,000	-5,131,000	-5,090,000	-5,034,000	-4,533,000	-4,083,000	-3,716,000	-3,743,000	-3,801,000	-3,454,000	-3,303,000	-3,684,000	-3,408,000	-3,367,000	-3,481,000	-3,088,000	-3,072,000	-3,426,000	-2,990,000	-2,977,000	-3,201,000	-2,742,000	-2,739,000	-1,355,000	-1,449,000
capital stock surrendered to pay taxes on stock-based compensation	-2,230,000	-6,254,000	-630,000	-2,867,000	-235,000	-5,725,000	-4,111,000	-133,000	-2,147,000	-3,166,000	-3,114,000	-382,000	-7,222,000	-4,893,000	-5,684,000	-847,000	-1,985,000	-6,613,000	-6,621,000	-3,862,000	-6,894,000	-7,951,000	-2,366,000	-11,224,000	-8,507,000	-6,377,000	-5,350,000	-412,000	-5,464,000	-2,578,000	-627,000	-2,916,000	-11,000	-880,000	-3,389,000
change in cash overdrafts payable	-129,000	438,000		0	-13,634,000	-2,115,000						3,819,000	8,767,000	-7,051,000						0	0	-9,849,000		-9,245,000	8,381,000	-6,671,000
other sources/	933,000	159,000					767,000	-1,667,000	1,614,000	122,000						-733,000	522,000	274,000					183,000	-89,000	389,000	-5,000							-91,000	37,000	-419,000	171,000	46,000	311,000						270,000		1,524,000
net cash used by financing activities	-47,103,000	-23,538,000	-212,494,000	-56,453,000	-74,475,000	-15,772,000	-6,085,000	-263,000	-13,926,000	-59,551,000	-14,366,000	-39,597,000	-53,413,000	-101,877,000	-45,373,000	-165,955,000	-127,477,000	-41,815,000	-21,005,000	-21,981,000	-183,186,000	-45,040,000	-53,414,000	26,218,000	-33,255,000	-48,711,000	-26,354,000			-2,953,000			-73,677,000			-1,108,000	-11,027,000	-2,126,000	-77,949,000	1,846,000	-32,431,000	-1,920,000	-9,050,000	-2,394,000	-12,758,000	-20,377,000
increase/(decrease) in cash and cash equivalents						49,392,000	90,808,000	13,226,000																			5,745,000	4,370,000	14,203,000	-9,351,000	-11,566,000	-44,939,000			3,425,000			-3,867,000	-29,599,000	-8,804,000	9,828,000
cash and cash equivalents at beginning of period	0	178,350,000		0	0	263,958,000		0	0	74,126,000
cash and cash equivalents at end of period	76,022,000	173,882,000		15,548,000	-90,447,000	313,350,000		13,226,000	101,870,000	58,054,000		-1,859,000	-8,520,000	18,160,000		-63,377,000	-118,036,000	210,156,000		92,389,000	-8,575,000	28,951,000		5,743,000	-10,363,000	13,686,000	5,745,000	4,370,000	28,335,000	-9,351,000	-11,566,000	39,479,000	-29,843,000	40,091,000	72,956,000	9,330,000	25,752,000	34,214,000	-29,599,000	-8,804,000	59,745,000	28,377,000	-3,039,000	112,119,000	11,859,000	29,704,000
see accompanying notes to unaudited consolidated financial statements.
(increase)/decrease in accounts receivable		-67,424,000								-14,318,000																																			-12,399,000
decrease in inventories		403,000																318,000								60,000			2,000			27,000	-573,000	403,000	499,000
(decrease)/increase in cash and cash equivalents		-4,468,000	-60,101,000	15,548,000										-14,735,000	4,152,000	-63,377,000																											-3,039,000	-297,000
adjustments to reconcile net income to net cash from operations:
noncash portion of long-term incentive compensation
(benefit)/benefit from deferred income taxes							205,000
deferred payroll taxes																			13,409,000	12,225,000
decrease/(increase) in accounts receivable						5,345,000															427,000	6,269,000								-43,245,000			-6,452,000					-34,949,000			17,923,000
decrease/(increase) in inventories			1,706,000	836,000	-13,000	1,302,000																149,000														507,000	322,000	200,000
decrease in prepaid expenses					-634,000	1,909,000		-938,000	483,000	1,236,000			590,000	3,099,000				4,402,000				1,211,000				1,045,000												1,833,000			747,000			502,000
(decrease)/increase in accounts payable and other current liabilities																						-7,037,000
increase in other assets			-4,490,000	-5,736,000	-3,122,000	-12,243,000	-1,330,000			-2,173,000	-3,355,000			-1,562,000	3,256,000	-3,473,000			-2,188,000	-6,658,000			-3,818,000	-3,492,000	-390,000	-4,263,000	1,624,000	586,000	-2,815,000	-390,000	-1,679,000	-1,069,000	-88,000	-1,843,000	-3,071,000	-1,661,000	1,371,000	-3,654,000	1,841,000	-1,985,000	-3,667,000			-1,672,000	-203,000	-293,000
increase/(decrease) in other liabilities							1,376,000	4,082,000										5,759,000																								1,022,000
change in cash overdraft payable
payments on other long-term debt							0	0			-1,250,000															-2,500,000	-1,875,000
proceeds from other long-term debt											0	0
payments on revolving line of credit											-7,400,000	-36,100,000	-176,800,000	-86,500,000	-23,800,000				0	0	-160,800,000	-104,100,000	-122,200,000	-132,900,000	-136,500,000	-90,500,000	-20,000,000			-48,300,000
proceeds from revolving line of credit											5,300,000	21,400,000	73,600,000	21,500,000	208,800,000				0	0	800,000	174,100,000	82,200,000	177,900,000	88,500,000	134,300,000	0			63,100,000
debt issuance costs											-2,000	-74,000																		0			-4,000	3,000	-1,107,000				0	-15,000	-2,708,000
other (uses)/sources										-130,000	215,000	262,000	-488,000	-15,000						-333,000	1,062,000	-1,116,000			91,000	-228,000																			-176,000
cash and cash equivalents at beginning of year											0	0	0	32,895,000	0	0	0	162,675,000	0	0	0	6,158,000	0	0	-6,290,000	11,121,000	0	0	14,132,000	0	0	84,418,000	0	0	69,531,000	0	0	38,081,000	0	0	49,917,000	0	0	112,416,000	3,628,000	4,988,000
cash and cash equivalents at end of year
the notes to consolidated financial statements are integral parts of these statements.
increase in inventories							507,000	-827,000	-1,021,000	-391,000		227,000				-983,000				-79,000				-1,018,000															-206,000	-715,000	-239,000	27,000	-369,000	-66,000	-514,000	-843,000
decrease/(increase) in prepaid expenses											1,140,000																		1,433,000				-4,166,000	-925,000	-1,092,000
benefit of deferred income taxes
decrease in accounts receivable												15,279,000	-18,723,000	19,610,000		4,525,000	-18,051,000	22,773,000								1,591,000																				12,112,000
increase/(decrease) in accounts payable and other current liabilities																														3,904,000												9,444,000
(increase)/decrease in other assets
payments on long-term debt										-76,250,000
decrease in cash and cash equivalents										-16,072,000		-1,859,000
benefit from deferred income taxes																																						-3,397,000	-1,590,000	-832,000	814,000	-1,522,000	-82,000	-2,282,000	-1,529,000	-1,126,000
increase in accounts payable and other current liabilities															3,502,000				-15,430,000				-205,000
(decrease)/increase in other liabilities											3,205,000	-5,064,000										-6,067,000
provision/(benefit) for deferred income taxes																		-930,000		-1,886,000	427,000	2,290,000
litigation settlements paid previously accrued
benefit from bad debts																					277,000	594,000
payments on previously accrued litigation settlements																		-8,490,000
provision/
loss on sale of transportation equipment
increase in prepaid expenses															-394,000				-955,000	-2,039,000			3,345,000	-4,535,000							-2,189,000	-1,112,000
unutilized cares act grant																				8,805,000
business combinations																				0	-2,148,000	-1,452,000				-1,450,000
litigation settlements paid
increase in cash and cash equivalents																		47,481,000				22,793,000		5,743,000	-4,073,000	2,565,000							-29,843,000												8,231,000	24,716,000
accrued litigation settlement
amortization of restricted stock awards																										291,000
litigation settlement																								0
asset impairment loss																								0
benefit from uncollectible accounts receivable																											3,366,000	3,930,000	3,804,000	3,124,000	3,145,000	3,304,000	2,779,000	2,465,000	2,967,000	2,573,000	2,485,000	2,245,000	2,275,000	2,254,000	2,111,000	2,385,000	2,391,000	2,472,000	3,071,000	2,002,000
increase in income taxes																										13,642,000			11,696,000			5,322,000			10,139,000			15,532,000	8,515,000	-6,001,000	9,739,000			13,955,000	13,056,000	6,677,000
potential litigation settlement
noncash early retirement expense
excess tax benefit on share-based compensation																											-4,476,000	-1,098,000	-2,900,000	-1,871,000	-467,000	-1,399,000	-29,000	-587,000	-1,891,000	-1,645,000	-272,000	-797,000	-29,000	-1,444,000	-1,895,000	-21,000	-667,000	-1,135,000	-145,000	-825,000
proceeds from long-term debt																													37,200,000
deferred income taxes																											89,000	-49,000	-2,734,000	-550,000	-661,000	6,841,000	-6,306,000	-4,694,000	-681,000	-1,913,000
amortization of discount on convertible notes																														0	1,131,000	2,261,000	2,186,000	2,150,000	2,114,000	2,043,000	2,010,000	1,975,000	1,909,000	1,878,000	1,846,000	1,784,000	1,755,000	1,726,000	1,612,000
changes in operating assets and liabilities, excluding
amounts acquired in business combinations:
retirement of warrants																														0
increase/(decrease) in cash overdrafts payable																													-1,528,000			369,000		-8,443,000	-3,165,000	-4,284,000	759,000	226,000
increase/(decrease) in income taxes
decrease in cash overdrafts payable																																								496,000	-8,310,000		-98,000	-1,216,000	-342,000	-963,000
net cash provided/(used) by operating activities																													12,374,000			-11,846,000
payment on long-term debt																													-23,450,000
net cash provided/(used) by financing activities																													10,031,000			-24,741,000			612,000
repayment of convertible notes
proceeds from issuance of term loan
decrease in income taxes
proceeds from issuance of capital stock																																				6,813,000	2,628,000	1,042,000	281,000	4,051,000	3,647,000	157,000	803,000	2,672,000
see accompanying notes to unaudited financial statements.
adjustments to reconcile net income to net cash from operating activities:
changes in operating assets and liabilities, excluding amounts acquired in business combinations:
proceeds from sales of property and equipment																																									33,000	93,000	62,000	27,000	1,360,000	19,000
changes in cash overdrafts payable
repayment of long-term debt																																													-10,799,000	-2,595,000
net decrease in revolving line of credit
decrease in prepaid expenses and other current assets																																													1,002,000
net proceeds/(uses) from the sale of discontinued operations
increase/(decrease) in cash overdraft payable
net proceeds/(uses) from the disposition of discontinued operations																																													-121,000
net cash provided/(used) by investing activities																																													-4,112,000	5,562,000
adjustments to reconcile net income to net cash provided by
operating activities:
discontinued operations
write off unamortized debt issuance costs
decrease in prepaid expenses and other
current assets
net sources/(uses) from disposals of discontinued operations
increase in cash overdraft payable
issuance of capital stock
proceeds from issuance of long-term debt
purchases of note hedges
proceeds from issuance of warrants
amounts acquired in business combinations
decrease in prepaid expenses and
other current assets																																														1,488,000
net sources/(uses) from the disposition of discontinued operations																																														9,556,000

We provide you with 20 years of cash flow statements for Chemed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Chemed stock. Explore the full financial landscape of Chemed stock with our expertly curated income statements.

The information provided in this report about Chemed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.